Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

A novel protein is lower expressed in renal cell carcinoma.

Guan R, Xu Y, Lei H, Gao Z, Xin Z, Guo Y.

Int J Mol Sci. 2014 Apr 29;15(5):7398-408. doi: 10.3390/ijms15057398.

2.

Engrailed-2 is down-regulated but also ectopically expressed in clear cell renal cell carcinoma.

Lai CY, Pan B, Luo Y, Liang WB, Chen J, Ye DM, Guo JN, Li L, Su ZX.

Mol Biol Rep. 2014 Jun;41(6):3651-7. doi: 10.1007/s11033-014-3229-z.

PMID:
24532139
3.

High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.

Kruck S, Merseburger AS, Hennenlotter J, Scharpf M, Eyrich C, Amend B, Sievert KD, Stenzl A, Bedke J.

BJU Int. 2012 May;109(10):1565-70. doi: 10.1111/j.1464-410X.2011.10649.x.

4.

The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.

Senanayake U, Koller K, Pichler M, Leuschner I, Strohmaier H, Hadler U, Das S, Hoefler G, Guertl B.

Hum Pathol. 2013 Mar;44(3):336-45. doi: 10.1016/j.humpath.2012.05.021.

PMID:
22995329
5.

Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.

Kauffman EC, Barocas DA, Chen YT, Yang XJ, Scherr DS, Tu JJ.

J Urol. 2009 May;181(5):2305-11. doi: 10.1016/j.juro.2009.01.003.

PMID:
19303095
6.

Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney.

Wagener N, Crnković-Mertens I, Vetter C, Macher-Göppinger S, Bedke J, Gröne EF, Zentgraf H, Pritsch M, Hoppe-Seyler K, Buse S, Haferkamp A, Autschbach F, Hohenfellner M, Hoppe-Seyler F.

Br J Cancer. 2007 Nov 5;97(9):1271-6.

7.
8.

Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.

Balamurugan K, Luu VD, Kaufmann MR, Hofmann VS, Boysen G, Barth S, Bordoli MR, Stiehl DP, Moch H, Schraml P, Wenger RH, Camenisch G.

Oncogene. 2009 Sep 17;28(37):3274-85. doi: 10.1038/onc.2009.186.

PMID:
19581925
9.

Expression and clinical significance of RCDG1 in renal cell carcinoma: a novel renal cancer‑associated gene.

Yu Z, Ni L, Chen D, Su Z, Yu W, Zhang Q, Wang Y, Li C, Gui Y, Lai Y.

Mol Med Rep. 2014 Sep;10(3):1583-9. doi: 10.3892/mmr.2014.2388.

PMID:
25059753
10.

Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis.

Zhang S, Fang J, Zhang X, Qin C, Su S, Deng Y, Song Z, Zhang Y, Wang H, Yin C, Wang Z.

Tumour Biol. 2014 Sep;35(9):9095-100. doi: 10.1007/s13277-014-2184-6.

PMID:
25027395
11.

Expression of human mucin genes in normal kidney and renal cell carcinoma.

Leroy X, Copin MC, Devisme L, Buisine MP, Aubert JP, Gosselin B, Porchet N.

Histopathology. 2002 May;40(5):450-7.

PMID:
12010365
12.

Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.

Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, Marinelli RJ, Presti JC Jr, van de Rijn M, Brooks JD.

Am J Surg Pathol. 2007 May;31(5):673-80.

PMID:
17460449
13.

Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR.

Argani P, Laé M, Hutchinson B, Reuter VE, Collins MH, Perentesis J, Tomaszewski JE, Brooks JS, Acs G, Bridge JA, Vargas SO, Davis IJ, Fisher DE, Ladanyi M.

Am J Surg Pathol. 2005 Feb;29(2):230-40.

PMID:
15644781
14.

Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.

Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M.

J Urol. 2008 Oct;180(4):1284-9. doi: 10.1016/j.juro.2008.06.036.

PMID:
18707725
15.

Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.

Zhang Z, Li J, Zheng H, Yu C, Chen J, Liu Z, Li M, Zeng M, Zhou F, Song L.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2685-93. doi: 10.1158/1055-9965.EPI-09-0097.

16.

Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.

Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ.

Carcinogenesis. 2006 Mar;27(3):499-507.

17.

The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.

Lichner Z, Scorilas A, White NM, Girgis AH, Rotstein L, Wiegand KC, Latif A, Chow C, Huntsman D, Yousef GM.

Am J Pathol. 2013 Apr;182(4):1163-70. doi: 10.1016/j.ajpath.2013.01.007.

PMID:
23416164
18.

Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.

Ma X, Fan Y, Gao Y, Zhang Y, Huang Q, Ai Q, Ni D, Chen W, Zhang P, Song E, Wang B, Shi T, Zheng T, Zhang X.

Urol Oncol. 2014 Jan;32(1):46.e9-17. doi: 10.1016/j.urolonc.2013.06.011.

PMID:
24094887
19.

Differential gene expression identifies subgroups of renal cell carcinoma.

Skubitz KM, Zimmermann W, Kammerer R, Pambuccian S, Skubitz AP.

J Lab Clin Med. 2006 May;147(5):250-67. Erratum in: J Lab Clin Med. 2007 Mar;149(3):163. Zimmerman, Wolfgang [corrected to Zimmermann, Wolfgang].

PMID:
16697773
20.

DNA mismatch repair genes in renal cell carcinoma.

Deguchi M, Shiina H, Igawa M, Kaneuchi M, Nakajima K, Dahiya R.

J Urol. 2003 Jun;169(6):2365-71.

PMID:
12771799
Items per page

Supplemental Content

Support Center